Trading Signals: HALO Stock Price Prediction and Forecast (Mon. Aug. 10, 2015 - Wed. Sep. 27, 2023)(Halozyme Therapeutics Inc)
| HALO latest price $41.9600 (-0.71%) ($41.9600 - $41.9600) on Wed. May. 26, 2021. | |
| | Trend Analysis and Forecast | | | Average Daily Percentage Swing | 2.35% (three month average) | RSI | 23 | Latest Price | $41.9600(-0.71%) | Stocks Behave Similarly | Similar Stock List | Weekly Trend | HALO declines -3.3% a week on average for past two weeks. | Market Behavior | Normal for large cap. Broad based rally for small cap. | Correlated ETFs | Broad market will support HALO advance at 0% a week (0% probability) IBB(50%) IWO(50%) IWM(48%) IWC(44%) IWN(43%) | Factors Impacting HALO price | HALO will decline at least -1.175% in a week (0% probabilities). VIXM(-31%) VXX(-12%) UUP(-11%) GLD(-1%) TLT(-0%) | | | | | Relative Volatility | (options are extremely cheap) | | | Market Trend Strength | -1.175% (StdDev 2.35%) | Hourly BBV | -0 () | Intraday Trend | 0% | | | |
|
1 - 5 Day Possible Target | $28.67(-31.67%) | Resistance Level | $44.64 | 5 Day Moving Average | $42.24(-0.66%) | 10 Day Moving Average | $42.3(-0.8%) | 20 Day Moving Average | $44.64(-6%) | To recent high | -18% | To recent low | 6% | Market Cap | $5.735b | | | | Halozyme Therapeutics, Inc. is a biopharmaceutical company, which engages in research, development & commercialization of human enzymes and drug candidates. It focuses on novel oncology therapies that target the tumor microenvironment. Its products include PEGPH20, HTI-1511, PEG-ADA2, and HYLENEX recombinant. The company was founded by Gregory Ian Frost on February 26, 1998 and is headquartered in San Diego, CA. |